382 related articles for article (PubMed ID: 20123462)
1. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R
Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
[TBL] [Abstract][Full Text] [Related]
2. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
[TBL] [Abstract][Full Text] [Related]
4. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
Anastasoaie V; Kurzius L; Forbes P; Waisbren S
Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
[TBL] [Abstract][Full Text] [Related]
5. Visual event-related potentials in children with phenylketonuria.
Henderson RM; McCulloch DL; Herbert AM; Robinson PH; Taylor MJ
Acta Paediatr; 2000 Jan; 89(1):52-7. PubMed ID: 10677058
[TBL] [Abstract][Full Text] [Related]
6. Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control.
de Sonneville LM; Huijbregts SC; Licht R; Sergeant JA; van Spronsen FJ
J Inherit Metab Dis; 2011 Aug; 34(4):953-62. PubMed ID: 21541727
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
Diamond A
Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
[TBL] [Abstract][Full Text] [Related]
9. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
[TBL] [Abstract][Full Text] [Related]
10. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
11. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
[TBL] [Abstract][Full Text] [Related]
12. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
Sharman R; Sullivan K; Young R; McGill J
Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
[TBL] [Abstract][Full Text] [Related]
13. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.
Schmidt E; Burgard P; Rupp A
Eur J Pediatr; 1996 Jul; 155 Suppl 1():S82-6. PubMed ID: 8828617
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
Sharman R; Sullivan K; Young R; McGill J
Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
[TBL] [Abstract][Full Text] [Related]
15. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations.
Huijbregts SC; de Sonneville LM; Licht R; van Spronsen FJ; Verkerk PH; Sergeant JA
Neuropsychologia; 2002; 40(1):7-15. PubMed ID: 11595258
[TBL] [Abstract][Full Text] [Related]
16. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
[TBL] [Abstract][Full Text] [Related]
17. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
[TBL] [Abstract][Full Text] [Related]
18. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
Seashore MR; Friedman E; Novelly RA; Bapat V
Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322
[TBL] [Abstract][Full Text] [Related]
19. Executive functioning in children and adolescents with phenylketonuria.
VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
[TBL] [Abstract][Full Text] [Related]
20. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria.
Schulpis KH; Tsakiris S; Traeger-Synodinos J; Papassotiriou I
Clin Biochem; 2005 Mar; 38(3):239-42. PubMed ID: 15708545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
